Hot Investor Mandate 2: Global Biotech Firm Seeks to Expands Pipeline in Oncology, Rare Diseases and Neuro Therapeutics

8 Jun

A global biotech company headquartered in France is actively seeking to expand its pipeline by working with early stage biotechs and academic groups. The company is open to a variety of deal structures and seeks to construct deals that maximize the potential of the therapeutic program.

The firm is focused on oncology, rare disease, and select neuroscience drug assets. The firm is interested in highly differentiated late stage pre-clinical and clinical stage therapeutic candidates with strong scientific rationale targeting indications with significant unmet medical need.

The firm has no strict requirements for companies or management teams and looks to work creatively and collaboratively on partnerships with early-stage companies. The firm is open to opportunities/companies on a global basis.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: